We added clinical trials for people with triple-negative, HER2-positive, and other subtypes of metastatic (stage IV) breast cancer to Metastatic Trial Search during the last month.
Stage IV Triple-Negative Trials
- Radiation Therapy, Immunotherapy, and a PARP Inhibitor for Women with Advanced Triple Negative Breast Cancer
Stage IV HER2-Positive Trials
Other Stage IV Trials
Last Modified on May 6, 2021